Trillium Therapeutics

Developer of therapeutics for the treatment of cancer

placeToronto, Ontario, Canada calendar_todayFounded 1996 groups33 employees language trilliumtherapeutics.com

Innovation

40 patent families (22 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 1,499 times.

YearFilings
20123
20132
20142
20152
20165
20178
201811
201913
202014
20219
20225
20241

Investor mix

8 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital563%
Private equity225%
Other / undisclosed113%
Coming soon